Top

Category: Editorial


Editorial

Emerging Technologies That Will Transform the Pharmaceutical Industry

December 29, 2022

Via: Sandra Ferguson

The pharmaceutical sector is highly capital-intensive and competitive, with new technologies and innovations being developed all the time. As the industry transitions to the digital age, emerging inventions are transforming the way drugs are developed, tested, and marketed. These technologies […]


Editorial

Could Drug Repurposing Change the Future of Biopharma?

December 27, 2022

Via: Natalie Dunn

The COVID-19 pandemic has taught scientists, policymakers, and individuals around the world many lessons about the future of both healthcare systems and the biopharmaceutical industry. Moreover, this new virus and the disease it caused has also prompted numerous companies operating […]


Editorial

The Future of Gene Therapy: Recent Advancements May Help Cure A Variety of Diseases

November 25, 2022

Via: Isabella Carter

Gene therapy is a medical field that focuses on developing personalized treatments that have the potential to save or change lives by inactivating a defective gene or replacing it with a functional one. As AI has already proven its ability […]


Editorial

5 New Drugs Could Reshape Healthcare for the Better

October 19, 2022

Via: Natalie Dunn

There is no question that the recent COVID-19 pandemic has not only dramatically affected the lives of people around the world, but also shed light on the many shortcomings plaguing the healthcare and biopharmaceutical industries. The healthcare systems of several […]


Editorial

Understanding and Treating the Symptoms of Long COVID

September 26, 2022

Via: Natalie Dunn

The recent COVID-19 pandemic undoubtedly reshaped healthcare systems around the world, while also increasing the pressure to develop and deliver better vaccines and treatments. Biopharmaceutical companies everywhere raced to find the first vaccine and the most effective drug as the […]


Editorial

Developing an Effective Response to the Monkeypox Outbreak

August 31, 2022

Via: Natalie Dunn

People around the world, scientists, and policymakers have undoubtedly learned numerous lessons from the COVID-19 pandemic. This healthcare crisis has shown the importance of being prepared to face a new epidemic or pandemic, as well as the need to develop […]


Editorial

New Drugs Could Help Patients with Serious Brain Disorders

July 22, 2022

Via: Natalie Dunn

While the COVID-19 pandemic wreaked havoc and forced scientists and policymakers to create or search for vaccines and treatments, common disorders continued to affect millions of human lives. The pandemic made it harder for people suffering from chronic conditions to […]


Editorial

How Past Infectious Diseases Can Become Future Opportunities

June 22, 2022

Via: Natalie Dunn

At the beginning of the COVID-19 pandemic, people around the world were comparing the new disease with the flu, also known as influenza. However, while both diseases cause respiratory symptoms, it soon became very clear that there are some important […]


Editorial

Is Childhood Vaccination Disrupted by Excessive Use of Antibiotics?

May 16, 2022

Via: Natalie Dunn

Nothing could make the benefits of vaccination easier to understand than the recent COVID-19 pandemic and its catastrophic effects. However, when it comes to vaccinating children and teenagers, many people around the world showed reluctance due to the potential negative […]


Editorial

3 Reasons Why Cloud Contact Centres Are the Next Step in Customer Success

April 25, 2022

Via: Nakisani Jacobs

At the same time that the implications of the global pandemic have created difficulties for many, they have also sparked an opportunity for growth and change.  One key area that has continued to evolve even as we return to a […]


Editorial

Developing COVID-19 Vaccines and Treatments for Children

April 8, 2022

Via: Natalie Dunn

More than two years have now passed since the beginning of the COVID-19 pandemic—an epidemic that turned into the most serious healthcare crisis in modern history. According to Johns Hopkins University, 6.16 million people have lost their lives to the […]


Editorial

Recent Global Crises Disrupt Cancer Research

March 21, 2022

Via: Natalie Dunn

The recent healthcare crisis differed from earlier emergencies because it has spread to impact most industries and multiple financial systems around the world. As the COVID-19 pandemic continued for more than two years, countries around the world struggled to keep […]


Editorial

New Drugs Provide Hope to Numerous Patients

February 22, 2022

Via: Natalie Dunn

As the Omicron variant of the virus that caused the current pandemic spreads and mutates, people are left hoping this will be the end of the healthcare crisis. Unlike previous variants, Omicron seems to be more infectious but less severe. […]


Editorial

What does the future hold for Biopharma?

December 29, 2021

Via: Abby Hallett

The COVID-19 pandemic has demonstrated that it is essential for biopharmaceutical organizations to act quickly and become flexible in production.  Experts, such as the CHEManager International team, view four factors as unsolved challenges. They claim that the first challenge is […]


Editorial

Could antiviral pills change the COVID-19 pandemic?

November 30, 2021

Via: Natalie Dunn

Almost two years have passed since the beginning of the COVID-19 pandemic that reshaped the world as we knew it. The virus responsible for the disease not only infected millions of people around the world, but also changed the way […]


Editorial

Do COVID-19 boosters increase immune response?

October 29, 2021

Via: Natalie Dunn

As the COVID-19 pandemic continues to spread across the globe, many people are worried that the current vaccination may not be sufficient to curb the spread of the virus. While the successful development of effective vaccines has been one of […]


Editorial

Is the New Merck Pill a Valuable Weapon Against the COVID-19 Pandemic?

September 30, 2021

Via: Natalie Dunn

The COVID-19 pandemic has reshaped industries—especially healthcare and biopharma.  While vaccines provided governments and people in the US and abroad with a new way of fighting the virus, more help is needed. As a significant percentage of the population remains […]


Editorial

Why Biopharma Industry Relies on New Science

August 30, 2021

Via: Natalie Dunn

The ongoing COVID-19 pandemic has sparked an unprecedented crisis for governments, healthcare providers, and industries across the world. Biopharmaceutical companies were especially affected, as they were left struggling to develop solutions that will ultimately help diagnose and treat those suffering […]


Editorial

Using Biopharma Breakthroughs to Fight the Delta Variant

July 30, 2021

Via: Natalie Dunn

The Delta variant of the coronavirus has become the dominant strain around the world, bringing with it an increase in deaths in the US and many other countries. While the victims are almost exclusively unvaccinated, the new surge seems to […]


Editorial

Biopharmaceuticals: A Look Into the Near Future

June 30, 2021

Via: David Dickson

In 1982, the U.S. approved human insulin—the first ever recombinant biopharmaceutical drug. Since then, biopharma development has proceeded at an exponential pace, with new innovations redefining, over and over again, the possibilities of medicine.  Going forward, biopharma will demand more […]